Carregant...
Management of hormone-receptor positive human epidermal receptor 2 negative advanced or metastatic breast cancers
Hormone therapy, rather than chemotherapy, is recommended for hormone-receptor positive (HR+), human epidermal receptor 2 negative (HER2−) advanced or metastatic breast cancer (A/MBC) according to the European Society of Medical Oncology (ESMO), American Society of Clinical Oncology (ASCO) and Natio...
Guardat en:
| Publicat a: | Ann Transl Med |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
AME Publishing Company
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6068330/ https://ncbi.nlm.nih.gov/pubmed/30105234 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2018.06.11 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|